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Abstract
Background: Intra-arterial thrombectomy is the gold standard treatment for large artery occlusive stroke. However,
the evidence of its benefits is almost entirely based on trials delivered by experienced neurointerventionists working in
established teams in neuroscience centres. Those responsible for the design and prospective reconfiguration of services
need access to a comprehensive and complementary array of information on which to base their decisions. This will help
to ensure the demonstrated effects from trials may be realised in practice and account for regional/local variations in
resources and skill-sets. One approach to elucidate the implementation preferences and considerations of key experts is a
Delphi survey. In order to support commissioning decisions, we aimed using an electronic Delphi survey to establish
consensus on the options for future organisation of thrombectomy services among physicians with clinical experience in
managing large artery occlusive stroke.
Methods: A Delphi survey was developed with 12 options for future organisation of thrombectomy services in England.
A purposive sampling strategy established an expert panel of stroke physicians from the British Association of Stroke
Physicians (BASP) Clinical Standards and/or Executive Membership that deliver 24/7 intravenous thrombolysis. Options
with aggregate scores falling within the lowest quartile were removed from the subsequent Delphi round. Options
reaching consensus following the two Delphi rounds were then ranked in a final exercise by both the wider BASP
membership and the British Society of Neuroradiologists (BSNR).
Results: Eleven stroke physicians from BASP completed the initial two Delphi rounds. Three options achieved consensus,
with subsequently wider BASP (97%, n= 43) and BSNR members (86%, n = 21) assigning the highest approval rankings in
the final exercise for transferring large artery occlusive stroke patients to nearest neuroscience centre for thrombectomy
based on local CT/CT Angiography.
Conclusions: The initial Delphi rounds ensured optimal reduction of options by an expert panel of stroke physicians,
while subsequent ranking exercises allowed remaining options to be ranked by a wider group of experts within stroke to
reach consensus. The preferred implementation option for thrombectomy is investigating suspected acute stroke patients
by CT/CT Angiography and secondary transfer of large artery occlusive stroke patients to the nearest neuroscience
(thrombectomy) centre.
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Background
There is an accruing body of evidence from multiple well
conducted randomised controlled trials (RCTs) illustrating
the benefits of intra-arterial mechanical thrombectomy
(IAT) compared with intravenous thrombolysis in acute is-
chaemic stroke caused by large artery occlusion. Recanali-
sation occurs in ~ 30% (range 10 to > 45%) of large artery
occlusive strokes (LAOS) after treatment with intravenous
thrombolysis [1, 2], whereas IAT with contemporary de-
vices achieves good recanalisation in > 70% in patients with
LAOS [3]. Level 1 evidence from multiple RCTs, including
one in the UK [4–11], demonstrates that IAT in patients
with anterior circulation acute LAOS is safe and efficacious
within six hours of stroke onset. Meta-analyses have con-
firmed an increased likelihood of improved functional out-
comes (mRS 0–2) at 90 days associated with IAT, with no
effect on mortality or symptomatic intracranial haemor-
rhage [12–15]. Trial data are however almost entirely based
on vascular imaging triage (Computed Tomographic or
Magnetic Resonance angiography of the brain) leading to
IAT delivered by experienced neurointerventionists work-
ing in established teams in neuroscience centres [5, 6, 8].
There is no level 1 data on outcomes of thrombectomy per-
formed by non neurointerventionists.
Currently very limited numbers of centres can deliver
IAT substantial variability in IAT service provision in
England as found in a survey of current interventional neu-
roradiology (INR) services in England (2014 population ~
54 million) [16]. The financial and workforce constraints
resulting in the variable provision and performance of INR
(and other clinical) services in England, have instigated calls
for service reconfiguration and the identification of cost-
effective models for optimal provision across the country.
There has been considerable debate over proposed or im-
plemented service reconfigurations within the National
Health Service (NHS) in England [17]. These types of deci-
sions are not fully informed by trial evidence and there is
often a lack of agreement between stakeholders, with lim-
ited options available to make the decision more objective.
To help inform decision making about IAT service
provision, a further appreciation of the preferences of clin-
ical experts is required. These preferences should form part
of the information underpinning the evidence base, which
should be clearly presented to decision makers responsible
for the design and implementation of service delivery pol-
icies within stroke care.
In order to support commissioning decisions, we
aimed to use an electronic Delphi survey to establish
consensus on the options for the future organisation of
thrombectomy services in England amongst physicians
with clinical experience in managing large artery occlu-
sive stroke; in the process helping demonstrate the feasi-
bility of the methods for informing service delivery
policy in other areas. We designed a Delphi and ranking
exercise to to focus on questions of “what could/should
be” relating to the organisation of health care services
[18–22]. The purpose of the study was to derive consen-
sus on thrombectomy service organisation. The Delphi
technique makes use of multiple iterations of responses
to questionnaires from a panel of experts to establish
consensus on a particular topic; multiple iterations
(rounds) provide the panellists with opportunities to re-
flect on feedback on their responses to statements in
previous iterations [18]. The Delphi survey was delivered
to physicians from NHS stroke clinical services that are
practising 24/7 intravenous (IV) thrombolysis. Data gen-
erated from this process will later be used to inform the
development of a health economic model to estimate
the effectiveness and cost-effectiveness of different
models of IAT services for the treatment of LAOS.
Methods
The data collection period for our study was November
2015 to January 2017. Participation was anonymous.
Contacts at the respective professional bodies were
aware of the identity of responders, but not the research
team. Contacts at the respective professional bodies for-
warded anonymised completed forms to the research
team via email.
Procedure for Delphi exercise
An request was sent to the chair of the British Associ-
ation of Stroke Physicians (BASP) Clinical Standards
Committee to disseminate a request for participation to
members. Stroke physicians currently employed within
an NHS stroke clinical service that delivers 24/7 IV
thrombolysis and were part of the BASP Clinical Stan-
dards and/or Executive Membership were eligible to par-
ticipate in the initial stage. The initial recruitment of
these stroke physicians for the Delphi exercise com-
prised a purposive sampling strategy predicated on the
grounds that – as part of their specialist training and
direct involvement in stroke care on a daily basis – they
possess critical knowledge and multidisciplinary team
skills in the diagnosis and treatment of stroke. Based on
the literature [26, 27], we aimed to recruit between 15
and 25 panellists who could provide a representative
pooling of ratings assigned to the options for future or-
ganisation of thrombectomy services. The initial Delphi
exercise served to delineate the options subsequently
presented in a ranking exercise (see later), which en-
gaged a wider range of relevant experts managing LAOS
and to strengthen the validity of our results by conver-
ging towards consensus on one proposition.
With reference to relevant literature [1–15], policy/
guidelines [23–25] and discussions within the study
team, a survey questionnaire was initially developed with
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12 options (the propositions) for future organisation of
thrombectomy services in England (see Table 1).
Piloting of the questionnaire was undertaken with mem-
bers of the research team and collaborating stroke physi-
cians. Participation was anonymous and correspondence
was managed by email using panellists’ BASP reference
numbers through the BASP secretariat. No more than
three rounds were planned, in order to ensure the process
did not become too repetitive and time-consuming to
maintain an adequate response rate [18]. After the second
Delphi round, three options fulfilled our pre-set criteria
for establishing consensus and were rated in the final
ranking exercise (see below).
In the first Delphi round each panellist was asked to
assign ratings using a 7-point Likert scale (1 = very
strongly disapprove to 7 = very strongly approve) to each
of the 12 options. Panellists were also given the oppor-
tunity to provide free text comments on the 12 options
at the end of the questionnaire.
In the subsequent Delphi round, panellists were in-
formed of aggregate-level summary statistics (mode, me-
dian and interquartile range) for the 12 options,
including (i) the individual ratings they had assigned to
each option in the previous round; and (ii) a brief sum-
mary of any free text comments. In addition, proposi-
tions with aggregate scores falling within the lowest
quartile from the first Delphi round (including all values
of 1, 2 and 3 on the Likert scale that represent very
strongly disapprove, quite strongly disapprove and disap-
prove, respectively) were removed from subsequent
rounds. Panellists in the second Delphi round were
asked to consider their ratings for the remaining propo-
sitions with reference to the data from the previous
round.
Consensus for “approval” was defined as ≥75% of the
panellists’ ratings for each option falling within three
categories (approve, quite or very strongly approve) on
the 7-point Likert scale. A period of two weeks was allo-
cated for panellists to respond to each round. Our cut-
off points for removal of propositions from subsequent
rounds and consensus were consistent with other Delphi
studies [26, 27, 29, 30].
Procedure for ranking exercise
Following the two-round Delphi exercise with BASP Clin-
ical Standards and/or Executive members from NHS stroke
clinical services that deliver 24/7 IV thrombolysis, proposi-
tions that reached consensus for approval were subjected to
a ranking exercise to establish wider professional stroke
physicians’ (see Additional file 1: Appendix 1) and neurora-
diologists’ (see Additional file 2: Appendix 2) preferences
on the remaining options.
A request for participation was sought from any mem-
ber of the BASP currently employed within the English
Table 1 Options (propositions) for Thrombectomy Service
Provision
Below we present a description of 12 potential options for delivering
thrombectomy with an explanatory footnotes (where required). Please
score each of the 12 options using a 7-point Likert scale:
1. Any local provider “ad hoc”a
2. Any local provider delivers IAT on a formal rotab
3. Transfer to nearest primary coronary percutaneous intervention
unit and cardiology managec
4. Transfer to nearest primary coronary percutaneous intervention
unit and shared care with stroke physiciansd
5. Ambulance bypass for all acute stroke patients of known time
onset to comprehensive stroke unit where advanced imaging
and “expert intra-arterial thrombectomy [IAT]” are available 24/7e
6. Local CT and transfer all patients with NIHSS ≥10 to the nearest
neuroscience centre for interventional neuroradiologist delivered
“expert thrombectomy”f
7. Local CT/CTA then transfer all large artery occlusive stroke
patients to nearest neuroscience centre for interventional
neuroradiologist delivered “expert thrombectomy”g
8. Local advanced imaging then selective transfer to nearest
neuroscience centre for “expert thrombectomy”h
9. Local CT/CTA then transfer large artery occlusive stroke patients
to nearest neuroscience centre for advanced imaging and “expert
thrombectomy”
10. Advanced imaging performed locally but interpreted centrally
by Neuroradiology then selective transfer to nearest neuroscience
centre for “expert thrombectomy”
11. Selective transfer to nearest on call neuroscience centre for
“expert thrombectomy”i
12. Interventional neuroradiologist and necessary support team
on standby in Neuroscience centre – they transfer to patient’s
hospital to deliver expert intra-arterial thrombectomy when large
arterial occlusion stroke is confirmedj
aAny physician with some intra-arterial catheter skills delivers intra-arterial
thrombectomy [IAT] as best they can when they can. There is no level I evidence
(obtained from at least one properly designed & conducted randomised controlled
trial) for this option
bInterventional radiologists would likely be at the core of this option. There is
no level I evidence for this option
cThere is no level I evidence for this option
dWhere a primary coronary percutaneous intervention unit and an acute
stroke unit are geographically close enough to allow this to be feasible
eAccording to data from the Sentinel Stroke National Audit Programme (SSNAP)
70% of acute stroke patients have known time onset and 60% of those reach
hospital within 4 h = 42%; 12% in SSNAP are haemorrhage not ischaemic strokes
fThis option is sometimes called a “drip and ship” approach; The neuroscience
centre team might include interventional neuroradiology trained/mentored
interventional radiologists or cardiologists to facilitate a 24/7 service
g37% of all stroke patients arrive at hospital within 4 h with ischaemic stroke
of known onset time. ~ 50% of patients have large artery occlusive strokes. So
IAT currently potentially applies to almost 20% of acute disabling ischaemic
strokes; Adjunctive IAT approach is proven (level 1 evidence) to increase mRS
0–2 by 12% to 14% with benefit across the Rankin scale of shift to
reduced disability
hSelective brain tissue viability assessment approach to IAT is proven (level 1
evidence) to increase mRS 0–2 by 24% to 31% with benefit across the Rankin
scale of shift to reduced disability; All RCT results are based on expert
interpretation of advanced imaging as triage for intra-arterial thrombectomy;
This option is a less time critical approach
iThis entails networking of Interventional Neuroradiology units to deliver 24/7 cover
sooner – with some longer transfer times, but does mean the efficacy data from
RCTs can be applied (underpinned by data for UK centres from the PISTE trial)
jThis is provided by very few places worldwide; This model of provision is
clearly very expensive
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NHS with clinical experience in managing LAOS. The
BASP encompasses members from a wide range of clin-
ical backgrounds (e.g. stroke, general medicine, geriatric,
neurology), with the association itself valuing this diver-
sity and the range of roles and services within stroke
care that its members provide [28]. As such, opening the
ranking exercise up to any member of the BASP high-
lights an inclusive approach (and validates a degree of
generalisability of opinions) of those who deliver stroke
care in England.
In addition, a parallel ranking exercise was conducted
with full members of the relevant special interest group
of the Royal College of Radiologists, the British Society
of Neuroradiologists (BSNR), currently employed within
an NHS service in the UK that delivers stroke imaging.
The view was taken that clinical neuroradiologists – due
to the remaining options all including the use of various
brain imaging techniques – would be particularly well
positioned, alongside the BASP membership, to help
reach consensus on options for the future delivery of
thrombectomy services.
Information on the outcomes of the preluding Delphi
exercise was provided to the wider BASP and BSNR
members participating in the ranking exercise. Participa-
tion was anonymous and correspondence with panellists
was managed by the Secretariat of professional societies’
using reference numbers.
The wider BASP and BSNR membership were asked
to rank options using a 7-point Likert scale (1 = very
strongly disapprove to 7 = very strongly approve). Re-
spondents were asked, in ranking, to use their experi-
ence and judgement to consider the availability,
practicality/deliverability and potential cost of each of
the different options. A free text box to write down any
comments was provided in both surveys. Two weeks
were given to members of the two professionals groups
to respond before a reminder was sent out with an add-
itional week before the survey was closed.
Summary statistics (frequencies, percentage fre-
quencies, median and IQR) for rankings assigned to
options by respondents from the wider BASP and
BSNR were calculated (see Tables 2 and 3 and Add-
itional file 3: Appendix 3). Free text responses asso-
ciated with options assigned high approval ratings
were subjected to a conceptual content analysis (see
Additional file 4: Appendix 4). This involved collat-
ing free text comments made for options with high
approval ratings. Emergent coding was then used to
summarise key themes for discussion between two
authors (DF and KH) who agreed on final themes,
which were peer-reviewed by the wider research
team. Final themes were supported by quotations, as
well as to permit readers to ascertain for themselves
their validity.
Results
Delphi exercise
Fifteen panellists from BASP completed the first Delphi
round. They comprised an experienced sample - with
67% having practiced as a stroke consultant for more
than 10 years. Panellists worked across all regions of
England (see Additional file 5: Appendix 5).
After the first Delphi round, the following three prop-
ositions had aggregate scores within the lowest quartile
indicating “disapproval” (see Table 1 for the proposi-
tions): Proposition 1 (87% very/quite strongly disapprove
or disapprove); Proposition 3 (87% very/quite strongly
disapprove or disapprove); Proposition 12 (60% very/
quite strongly disapprove or disapprove).
Eleven of the 15 panellists from the first round also
completed the second round of the Delphi exercise and
rated the remaining nine propositions (Table 2).
Following the second Delphi round, consensus “ap-
proval” was achieved for three propositions (see Table 1
for the propositions): Proposition 7 (91% very/quite
strongly approve or approve); Proposition 9 (82% very/
quite strongly approve or approve); Proposition 11 (100%
very/quite strongly approve or approve).
Ranking exercises with wider BASP membership and
BSNR
The wider BASP members were asked to rank the three
options that reached consensus approval in the two
rounds of the Delphi exercise. Propositions 7 and 9 were
designated as simple imaging and advanced imaging
driven options, respectively, with proposition 11 desig-
nated as a clinical judgement driven option in the final
ranking exercise.
BSNR members were also asked to rank these options.
However, due to their routine imaging practices in their
role as neuroradiologists, the advanced imaging driven
option was dichotomised into two options relating to
technical imaging pathways driven by (i) the Alberta
Stroke Program Early CT Score (ASPECTS) and collat-
eral scoring or (ii) computed tomography (CT) perfusion
parameters.
The wider BASP membership returned 43 surveys
(representing approximately 15% of the total member-
ship). The respondents had a range of experience - num-
ber with 0–5 years, 5–10 and 10+ years of experience as
a stroke physician was 10 (23%), 11 (26%) and 22 (51%),
respectively. The majority (n = 34, 79%) currently had ar-
rangements in place to refer patients for thrombectomy
(n = 14, 41% had formal arrangements and n = 20, 59%
had ad hoc arrangements). The BASP respondents came
from all regions of England.
A total of 21 responses were received from BSNR
members (also representing approximately 15% of all
BSNR members in the UK) with 62% practicing 10+
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years and 71% of respondents’ currently undertaking
regular cerebral vascular interventions. All regions of the
UK were represented.
Responses from the wider BASP and the BSNR mem-
bers are summarised in Table 3. There was a clear consen-
sus (97% of wider BASP and 86% of BSNR members very/
quite strongly approved or approved) for a simple imaging
driven pathway: patients with large artery occlusive stroke
are transferred to nearest [neuroscience] centre for thromb-
ectomy based on local CT/CT Angiography alone.
Discussion
Currently in England all thrombectomy is provided by
neurointerventionists - almost exclusively based in Regional
Neuroscience Centres. This Delphi and ranking exercise by
groups of practising NHS clinicians with regular clinical
expertise in the management of LAOS patients has consid-
ered implementation options for thrombectomy into rou-
tine stroke care pathways in England. The preferred option
is conveying suspected stroke patients to the nearest
hospital with a hyperacute acute stroke unit for CT/CT
Angiography brain imaging investigation and secondary
transfer of those identified as LAOS to nearest [neurosci-
ence] thrombectomy centre. Whilst the discussion focuses
on the LAOS scenario presented, the methods used have
the potential to be utilised when considering the implemen-
tation of any new service/treatment.
Strengths and limitations
This study provides policymakers and practitioners with
complementary data that previous trials on the effectiveness
of thrombectomy services have failed to capture, employing
a proven methodology in use since the 1950s [29, 30]. The
initial Delphi rounds ensured the optimal reduction of op-
tions by an expert panel of stroke physicians, while subse-
quent ranking exercises allowed remaining options to be
ranked by a wider group of experts. The iterative procedure
with multiple rounds contributed to enhancing the accur-
acy of results by converging towards consensus in favour of
one option.
The results of any Delphi and ranking exercise can be
susceptible to the interpretations and specific propos-
ition formulations of the study team which – if some-
what differently worded – might have nuanced the
findings [29]. This issue is accentuated by the fact that
participants are asked to rank pre-formulated and closed
options. However, we believe a strength of this study is
that a wide range of options (n = 12) were specified from
Table 2 Aggregate panellist responses (Likert Scale category) for each proposition, N = 11
Percentage Responses
Proposition Number (from original list in Table 1) 1 very
strongly
disapprove
2 quite
strongly
disapprove
3 disapprove 4 neutral 5 Approve 6 quite
strongly
approve
7 very
strongly
approve
2. Any local provider delivers IAT on a formal rota 55 18 27
4. Transfer to nearest primary coronary percutaneous
intervention unit and shared care with stroke physicians
18 18 37 18 9
5. Ambulance bypass for all acute stroke patients of
known time onset to comprehensive stroke unit
where advanced imaging and “expert intra-arterial
thrombectomy [IAT]” are available 24/7
9 55 18 18
6. Local CT and transfer all patients with NIHSS ≥10
to the nearest neuroscience centre for interventional
neuroradiologist delivered “expert thrombectomy” **
9 27 27 27
7. Local CT/CTA then transfer all large artery occlusive
stroke patients to nearest neuroscience centre for
interventional neuroradiologist delivered “expert
thrombectomy” **
27 37 27
8. Local advanced imaging then selective transfer
to nearest neuroscience centre for “expert thrombectomy”
18 18 18 37 9
9. Local CT/CTA then transfer large artery occlusive
stroke patients to nearest neuroscience centre for
advanced imaging and “expert thrombectomy”
18 18 46 18
10. Advanced imaging performed locally but
interpreted centrally by Neuroradiology then
selective transfer to nearest neuroscience centre
for “expert thrombectomy”
9 27 9 46 9
11. Selective transfer to nearest on call neuroscience
centre for “expert thrombectomy”
36 46 18
**N = 10
NB Propositions that achieved consensus approval have been highlighted in bold text. Percentages may not equal 100 due to rounding
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its inception. These options were informed by existing
research and policy guidelines on thrombectomy, in
addition to the attention to detail and extensive discus-
sions within an experienced research team. Although
recognising that some of these options are not equally
supported by available evidence and/or may be less feas-
ible in clinical practice, we included all of them as the
purpose of this Delphi and ranking exercise was to elim-
inate less effective, less deliverable and/or less cost-
effective options by consensus iteration from a wider
Table 3 Summary of results from ranking exercises
Wider BASP members (N = 43) Percentage Responses
Using your experience and judgement, please take the
following elements into consideration when assigning
scores to the options: availability; practicality/deliverability;
and cost (including of any additional software or hardware
likely to be required in your region)
1 very
strongly
disapprove
2 quite
strongly
disapprove
3 disapprove 4 neutral 5 approve 6 quite
strongly
approve
7 very
strongly
approve
1. Patients with large artery occlusive stroke are transferred
to nearest [neuroscience] centre for thrombectomy based
on local CT/CTA alonea
2 21 53 23
2. Patients are transferred to nearest [neuroscience] centre
for thrombectomy based on advanced imaging obtained
at referring hospitalb
12 5 16 23 21 16 7
3. Selective transfer to nearest on call [neuroscience]
thrombectomy centre for expert thrombectomyc
16 19 12 19 14 12 9
Using your experience and judgement, please take the
following elements into consideration when assigning
scores to the options: availability; practicality/deliverability;
and cost (including of any additional software or hardware
likely to be required in your region)
Whilst options 2 & 3 are both “Advanced Imaging Triage”
they may differ in deliverability, cost & practicality so they
have been separated out for this exercise. There is of
course uncertainty over the strength of evidence
supporting either option
Full members of the BSNR (N = 21) Percentage Responses
1. Patients are transferred for thrombectomy based
on local CT/CTA aloned
5 5 5 19 29 38
2. Patients are transferred for thrombectomy based
on formal ASPECTS & Collateral Scoring in addition to
confirming large artery occlusion present - “Advanced
Imaging Triage ACS”e**
24 29 14 14 14
3. Patients are transferred for thrombectomy based
on CT Perfusion parameters in addition to confirming
large artery occlusion present - “Advanced Imaging
Triage PERFUSION”f**
14 19 38 14 10
4. Selective transfer to nearest on call neuroscience
centre for “expert thrombectomy”g
5 29 5 29 5 29
**N = 20
a37% of all stroke patients arrive at hospital within 4 h with ischaemic stroke of known onset time. ~ 40–50% of patients have large artery occlusive strokes
Adjunctive IAT approach is proven (level 1 evidence) to increase mRS 0–2 by 12% to 14% with benefit across the Rankin scale of shift to reduced disability
Facilities will need to be available for the neurointerventionist to rapidly review CT/CTA prior to accepting a referral. This may require additional IT infrastructure
Responsibility for formal reporting will be with the centre acquiring the CT/CTA images unless other contractual arrangements are formally agreed
bSelective brain tissue viability assessment approach to IAT is proven (level 1 evidence) to increase mRS 0–2 by 24% to 31% with benefit across the Rankin scale of shift
to reduced disability. All RCT results are based on expert interpretation of advanced imaging as triage for intra-arterial thrombectomy. Facilities will need to be available
for the neurointerventionist to rapidly review imaging prior to accepting a referral. This will require additional IT infrastructure. Responsibility for formal reporting will be
with the centre acquiring the imaging unless other contractual arrangements are formally agreed
cThis is a flexible clinical judgement driven referral route – so that for example if plain CT shows an obvious hyper-dense MCA sign, the ASPECTS score is good (7
+) & NIHSS is ≥6, referral for thrombectomy is made without CTA if obtaining such locally would add significant delays. However, this may add delay downstream
in the pathway for thrombectomy as a second CT scanner visit will be required on arrival at receiving hospital. This may entail networking of Neurorinterventional
units to deliver 24/7 cover sooner- with some longer transfer times, but does mean the efficacy data from RCTs can be applied (underpinned by data for UK centres from
the PISTE trial)
dFacilities will need to be available for the neurointerventionist to rapidly review these prior to accepting a referral. This may require additional IT infrastructure.
Responsibility for formal reporting will be with the centre acquiring the CT/CTA images unless other contractual arrangements are formally agreed
eThis reflects evidence of ESCAPE trial. Footnotes above also apply to all these options
fThis reflects evidence of EXTEND/SWIFT PRIME trials. Footnotes to option 1 also apply. This may require a region wide adoption of a standardised protocol &
software such as RAPID or OLEA
gThis is a flexible clinical judgement driven referral route – so that for example if plain CT shows an obvious hyper-dense MCA sign, the ASPECTS score is good (7
+) & NIHSS is ≥6, referral for thrombectomy is made without CTA, which may add delay to the pathway to thrombectomy
NB The propositions that reached consensus from the respective groups have been highlighted in bold text. Percentages may not equal 100 due to rounding
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group of experts, rather than biasing the process by in-
cluding fewer options favoured by the research team. A
box for free text comments was additionally included
and respondents’ comments were considered by the re-
search team (see Additional file 4: Appendix 4).
A related matter is the composition of participants
[29]. Despite being confident that the various rounds
allowed the views of a qualified group of experts to be
voiced, it could be argued that the participation rate was
relatively modest with approximately 15% of the total
membership of the respective groups (BASP and BSNR)
participating in the final ranking exercise. Furthermore,
as eleven BASP members participated in the two initial
Delphi rounds, and some of the same respondents could
participate in the final ranking exercise by the wider
BASP membership. However, in a Delphi and ranking
exercise the term “representativeness” is not reflective of
how this term is understood within conventional survey
techniques. Complex treatment techniques in health
care such as thrombectomy are surrounded by uncer-
tainty and can only be addressed by a group of clinicians
with sufficient experience and knowledge in this field
[30]. Although acknowledging that the study may not be
representative of the full spectrum of stroke-related ex-
pertise and perspectives in England, it is notable that
participants had both extensive experience of treating
LAOS patients on a day-to-day basis – including many
with more than 10 years of clinical experience – but
were also geographically dispersed – with respondents’
from all different regions of England.
The study team also approached the Royal College of
Emergency Medicine (RCEM) regarding their potential in-
volvement in the final ranking exercise. However, in dis-
cussion with the College we were unable to identify a
process that would permit the questionnaire to be sent to
the small minority of emergency department physicians
with direct expertise/routine involvement in management
of LAOS patients (and who make IV thrombolysis deci-
sions – an even smaller minority). A previous position
statement from the RCEM has recognised that although
emergency medicine doctors are well suited to perform
complex treatments such as IV thrombolysis in certain
circumstances, this is not considered part of their “core”
work responsibilities [31].
Existing workload pressures may have affected the op-
tions chosen by participants. It is illustrative that select-
ive transfer to nearest neuroscience centre for “expert
thrombectomy” received a 100% approval rate in the
first two Delphi rounds with BASP Clinical Standards
and/or Executive members from NHS stroke clinical ser-
vices that deliver 24/7 IV thrombolysis, yet changed dra-
matically to a significant proportion either disapproving
or being neutral to the statement in the ranking exercise
with wider BASP membership and the BSNR members.
It could be postulated that this change was due to the
two Delphi rounds consisting of senior physicians who
are comfortable with a clinical selection process rather
than the additional novel imaging workload that is likely
to fall on them with the other options. Wider represen-
tation of BASP and BSNR members in the final ranking
exercises with the inclusion of neuroradiologists who, it
could be postulated, would predictably rate clinical se-
lection option lower than options that are based largely
on brain imaging.
Additionally, asking any healthcare professional about
the future organisation of services may be somewhat re-
stricted by current service configurations which, to a
greater or lesser extent, influence their thinking when
ranking options. Despite their experience in the field
putting the consulted experts in a prime position to as-
sess what has worked or not in the past and at present,
there are limits to peoples’ abilities or willingness to
comprehend configurations and practices beyond those
to which they have become accustomed. For instance,
the advanced imaging options in the final ranking exer-
cises may have been deemed less favourable due to the
current issues facing many NHS trusts in different parts
of the country in obtaining advanced imaging of an ad-
equate standard and on time [17]. Realities of the
present situation potentially inhibit innovative and more
effective solutions from being considered as future sce-
narios. Consequently, participants might assign a low
ranking to certain options and/or will be deterred from
proposing constructive changes. It may be imperative to
invest in other and supplementary forms of evidence
(see ‘further research’ below) to allow for the consider-
ation of more radical changes to current services than
are likely to be suggested through consulting healthcare
professionals in a Delphi and ranking exercise alone.
Clinical implications of findings
Enablers to implementation of the simple imaging driven
IAT pathway are driven by a perception that a clinical and
simple imaging driving pathway is a pragmatic approach,
with evidence of feasibility within the NHS for improving
outcomes without compromising safety [11]. This option
may also be optimally acceptable as it was considered to
expedite patient transfer and would not impact negatively
on the relaying of CT/CTA images to neuroscience cen-
tres and concomitant door-to-treatment times.
Emerging evidence from trials such as the DAWN-
trial showing effectiveness of thrombectomy beyond the
six-to-eight-hour window and up to 24 h after stroke on-
set (relating to functional outcomes at 90 days) [32], has
implications for the clinical significance of the finding
from this Delphi and ranking exercise. However, the
findings from the DAWN-trial do not represent the end
of the much-cited tenet in stroke care that “time is
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brain”. Against the backdrop of the emergence of new
evidence from the DAWN-trial, the potential for more
favourable outcomes of earlier thrombectomy, and the
persisting importance of time to treatment in stroke
care, should still be considered [33, 34]. For this Delphi
and ranking exercise, nevertheless, we cannot rule out
that awareness of the emerging DAWN-trial findings
amongst respondents (which had not been revealed at
the time of conducting the present study) may have im-
pacted on ratings assigned to the different propositions.
A potential barrier to implementing the simple imaging
driven IAT pathway is that sites would need to be able to
both undertake rapid CT/CTA and provide an expeditious
transfer of patients to thrombectomy centres. Without
providing efficient links between these components, the
clinical effectiveness of thrombectomy services as demon-
strated in available evidence [1–15] may not be replicated
in routine clinical practice. Implementation barriers to
achieving this is the documented variability of stroke care
provision across England – both at the pre-hospital and
hospital level – relating to costs, funding constraints, geo-
graphical location, availability of scanning facilities,
achieving outside “office hours” coverage and skill mix of
local clinical teams. For example, a review of organisa-
tional models of acute stroke care identified regional vari-
ation in capacity, expertise and a fragmented approach to
organisation of stroke care as barriers to implementation
of improved thrombolysis provision [35]. These barriers
have important implications for the feasibility of a simple
imaging driven IAT pathway in different localities, such as
known time delays between hospital transfers [17, 36].
Scope for regional/local flexibility needs to be built into
the design and implementation of the preferred option in
regards to the assessment of patients/imaging examina-
tions from individual trusts/centres, and the support of
rapid and accurate imaging in order to transfer all LAOS
patients appropriately.
Staff training in interpretation and decision making about
thrombectomy should also be a priority. This would include
training for Emergency Medical Services in the identifica-
tion/presentation of patients eligible for endovascular treat-
ment [23] and available services for inter-professional
training for all staff, as well as continued professional devel-
opment in the light of technological innovations and estab-
lishment of additional IT infrastructure. Concurrently, it is
important that any staff training does not impact upon the
usual services that either trainers or trainees would typically
deliver to patients [36].
Further research
Amidst funding constraints and the need to prioritise re-
sources, an extensive evidence base provides a founda-
tion upon which decision makers can formulate more
persuasive arguments for the reconfiguration of services.
One component of the evidence base is the implementation
preferences and considerations of those who deliver the ser-
vices in their routine day-to-day clinical practices. Whilst
arguing for the value of Delphi methods in providing this
key information, we are not advocating for an exclusive reli-
ance on the perspectives of the particular subset of stroke
experts represented in this study alone. Further research is
needed to evaluate the potential barriers/implications of the
simple imaging driven IAT pathway as outlined above and
to find practical solutions of addressing these. To further in-
form policymaking, for instance, the unique insights into the
perspectives of stroke experts obtained from this study can
be contextualised alongside other sources of evidence such
as RCTs that assess clinical outcomes of thrombectomy by
comparing organisation and transfer methods of services
[37]. In addition, in the case of LAOS more research is
needed to assess the clinical and cost-effectiveness of the
preferred option identified in our study compared to the
other options that attracted high approval rankings, but did
not reach consensus. There has been a relative paucity of re-
search on the prevalence of the implementation alternatives
associated with their costs [38, 39]; however the results of
this Delphi and ranking exercise (and a parallel exercise to
elicit preferences of stroke survivors/their carers and the
public on service configurations for delivery of thrombec-
tomy) will be used to inform/parameterise a health eco-
nomic model to evaluate the cost-utility (estimated using a
quality adjusted life years framework) of the simple imaging
driven IAT pathway and alternative service configurations in
England. This will provide policymakers and commissioners
with data on the flexibility of service specifications that take
into account variations in distance and travel time to appro-
priate centres, as well as patient characteristics and skill mix
of clinical teams and infrastructure/resources needed to pro-
vide a comprehensive thrombectomy service.
Conclusions
This Delphi and ranking exercise with clinical experts on
the future delivery of thrombectomy services in England
has established consensus on a “simple” imaging driven op-
tion, which advocates the secondary transfer of patients
with LAOS for thrombectomy based on local CT/CTA. IT
facilities and adequate staffing level/expertise are needed to
enable rapid review by (neuro) interventionists and,
where appropriate, secondary transfer of LAOS patients
to thrombectomy capable centres. The methods employed
here offer the potential to provide supplementary informa-
tion to aid policymakers and practitioners making deci-
sions on service reconfiguration, including the provision
of data on factors that will impact on implementation for
the prospective reconfiguration of stroke services. These
data can be assessed alongside other sources of evidence
and may, in particular, complement trials on the effective-
ness of thrombectomy.
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